Donald Trump's recent actions, including H-1B visa changes and pharmaceutical tariffs, have dealt a significant blow to Indian stock markets, thwarting a nascent rebound. This has led to foreign investor sell-offs and increased US-India tensions, resetting expectations for a year-end rally and raising concerns about economic growth.